Medscheme released updated MEDICINE EXCLUSION LIST APRIL 2023

Some items listed as REQUIRING PRE-AUTHORISATION:

• Forxiga (Dapagliflozin)
• Byetta (Exenatide)
• Janumet (Metformin/Sitagliptin)
• Onglyza (Saxagliptin)
• Januvia (Sitagliptin)
• Galvus (Vildagliptin) + including Metformin combinations
• Liptruzet (Atorvastatin/Ezetimibe)
• Ezetrol (Ezetimibe)
• Inegy(Ezetimibe/Simvastatin)

Details regarding the EXCLUDED ITEMS:

• Trulicity (Dulaglutide)
• Jardiance (Empagliflozin)
• Xultophy (Insulin Degludec and Liraglutide)
• Soliqua (Insulin Glargine and Lixisenatide)
• Victoza (Liraglutide)
• Synjardy (Metformin and Empagliflozin)
• Ozempic (Semaglutide)